Paraneoplastic syndromes in three patiënts with renal cell carcinoma;Een jongetje met cryptorchisme, een liesbreuk en vrouwelijke genitalia interna: Het persisterende-gang-van-Müller-syndroom

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 10, 2004, Pages 484-492

  Halbertsma, F J J ^a   Otten, B J ^a   Wijnen, R M H ^a   Feitz, W F J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME;

ABDOMINAL MASS; ADULT; ANEMIA; ARTICLE; CANCER MORTALITY; CASE REPORT; DISEASE ASSOCIATION; FEVER; FLANK PAIN; HEMATURIA; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPERTENSION; KIDNEY CARCINOMA; LIVER DYSFUNCTION; LIVER TOXICITY; MALE; METASTASIS; NEPHRECTOMY; PARANEOPLASTIC SYNDROME;

EID: 1542344552     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Visser O, Coebergh JWW, Schouten LJ. Incidence of cancer in the Netherlands 1992. Fourth report of the Netherlands Cancer Registry. Utrecht: Vereniging van Integrale Kankercentra; 1995. p. 52-4.
2. Belldegrun A, deKernion JB. Renal tumors. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's urology. 7th ed. Philadelphia: Saunders; 1998. p. 2283-326.
3. McDougal WS, Garnick MB. Clinical signs and symptoms of renal cell carcinoma. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, editors. Comprehensive textbook of genitourinary oncology. Baltimore: Williams & Wilkins; 1996. p. 154-9.
4. Tsukamoto T, Kumamoto Y, Miyao N, Masumori N, Takahashi A, Yanase M. Interleukin-6 in renal cell carcinoma. J Urol 1992;148:1778-81.
5. Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Schemann S, Negrier S, et al. Role of interleukin-6 in the paraneoplastie inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer 1997;72:424-30.
6. Strewker GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, et al. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 1987;80:1803-7.
7. Muggia FM. Overview of cancer-related hypercalcemia: epidemiology and etiology. Semin Oncol 1990;17(Suppl 5):3-9.
8. Gotoh A, Kitazawa S, Mizuno Y, Takenaka A, Arakawa S, Matsumoto O, et al. Common expression of parathyroid hormone-related protein and no correlation of calcium level in renal cell carcinomas. Cancer 1993;71:2803-6.
9. Lindop GB, Fleming S. Renin in renal cell carcinoma - an immunocytochemical study using an antibody to pure human renin. J Clin Pathol 1984;37:27-31.
10. Sufrin G, Mirand EA, Moore RH, Chu TM, Murphy GP. Hormones in renal cancer. J Urol 1977;117:433-8.
11. Dybedal I, Bryder D, Fossum A, Rusten LS, Jacobsen SE. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoetic stem cells. Blood 2001;98:1782-91.
12. Turkington RW. Ectopic production of prolactin. N Engl J Med 1971;285:1455-8.
13. Watanobe H, Yoshioka M, Takebe K. Ectopic ACTH syndrome due to Grawitz tumor. Horm Metab Res 1988;20:453-6.
14. Riggs BL, Sprague RG. Association of Cushing's syndrome and neoplastic disease: observations in 232 cases of Cushing's syndrome and review of the literature. Arch Intern Med 1961;108:841-9.
15. Jobe BA, Bierman MH, Mezzacappa FJ. Hyperglycemia as a paraneoplastic endocrinopathy in renal cell carcinoma: a case report and review of the literature. Nebr Med J 1993;78:349-51.
16. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987;237:893-6.
17. Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol 1996;14:216-22.
18. Hanash KA. The nonmetastatic hepatic dysfunction syndrome associated with renal cell carcinoma (hypernephroma): Stauffer's syndrome. Prog Clin Biol Res 1982;100:301-16.